Treatment of hepatitis C in hemodialysis patients using pegylated interferon alpha-2a in Turkey

---

Copy For Citation

Kose Ş., Gurkan A., Akman F., Kelesoglu M., Uner U.

JOURNAL OF GASTROENTEROLOGY, vol.44, no.4, pp.353-358, 2009 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 44 Issue: 4
• Publication Date: 2009
• Doi Number: 10.1007/s00535-009-0016-z
• Journal Name: JOURNAL OF GASTROENTEROLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.353-358
• Keywords: Pegylated interferon alpha-2a, Hepatitis C infection, Hemodialysis patients, RENAL-DISEASE, VIRUS, MONOTHERAPY, INFECTION, RIBAVIRIN, KIDNEY
• Dokuz Eylül University Affiliated: No

Abstract

Hepatitis C virus (HCV) is prevalent in renal insufficient patients. The aim of the present study was to evaluate the efficacy and tolerability of pegylated interferon alpha-2a (peg-IFN-alpha-2a) among these patients.